drugset
drugset / Trial / NCT05558150

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac

NCT05558150 ↗

Phase 1 Completed 24 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This study evaluate the pharmacokinetic drug interactions and safety after co-administration of ilaprazole and Aceclofenac in healthy adults.

Timeline

Start
2022-11-10
Primary completion
2022-12-14
Completion
2022-12-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Aceclofenac Small molecule 100 mg —
Subject Ilaprazole Small molecule 10 mg —

Indications

No indication recorded.